Tuesday, October 08, 2024
Marcelo A. F. Ribeiro Jr. Inducted into Prestigious American College of Surgeons Master Surgeon Academy
Marcelo A. F. Ribeiro Jr., MD, PhD, Professor of Surgery at the University of Maryland School of Medicine (UMSOM), was inducted into the American College of Surgeons (ACS) Academy of Master Surgeon Educators during an event in Chicago held on September 27. Dr. Ribeiro, who is also the Director of the International Outreach Initiative at R Adams Cowley Shock Trauma Center, is among a group of 76 esteemed surgeon educators nationwide who were inducted this year into membership in this distinguished Academy.
Wednesday, October 02, 2024
Early Results from Multiple Myeloma Clinical Trial Prove Cancer Drug Combination Provides Longer Response and Potential Benefit in Disease-Free Survival
Patients with multiple myeloma, a type of cancer in their white blood cells, have a significantly longer disease-free period and likely long-term survival if they are treated with the monoclonal antibody drug daratumumab along with the standard therapy drug lenalidomide compared to the standard therapy alone. That is the finding of a new national study led by University of Maryland School of Medicine investigators and presented earlier this week at the plenary session of the International Myeloma Society Meeting in Rio de Janerio, Brazil and published online in the journal Blood.
Tuesday, October 01, 2024
Cancer Patients Who Experience Cognitive Decline After Radiation Treatment for Brain Metastases May Regain Full Neurocognitive Function, New Study Suggests
Nearly 40 percent of cancer patients who experienced memory loss, brain fog and other cognitive difficulties after radiation treatment for brain metastases regained full neurocognitive function within six months, according to a new analysis by radiation oncology researchers at the University of Maryland Greenebaum Comprehensive Cancer Center (UMGCCC).
Wednesday, September 18, 2024
UM School of Medicine Establishes Three New Endowed Professorships through Maryland E-Nnovation Awards and UMB Matching Funds
University of Maryland School of Medicine (UMSOM) Dean Mark T. Gladwin, announced today that the School of Medicine has been awarded $2 million in matching funds from the Maryland E-Nnovation Initiative Fund (MEIF), administered by the Maryland Department of Commerce. The funds, totaling $4 million when combined with UMB private funding, will enable the establishment of three endowed research professorships.
Thursday, August 29, 2024
28th Annual White Coat Ceremony Welcomes UMSOM Class of 2028
The University of Maryland School of Medicine (UMSOM) welcomed 165 new students making their first entrance into the practice of medicine through the tradition of the White Coat Ceremony. The ceremony took place on August 9 with family, friends, faculty, and staff gathering at the historic Hippodrome Theatre to celebrate the Class of 2028 as students received the first white coat of their careers.
Wednesday, August 28, 2024
Leading Computational Scientist and Oncology Researcher Elana Fertig, PhD, Appointed as New Director of the Institute for Genome Sciences at the University of Maryland School of Medicine
University of Maryland School of Medicine (UMSOM) Dean Mark T. Gladwin, MD, announced today the appointment of Elana J. Fertig, PhD, FAIMBE, as the new Director of the School’s Institute for Genome Sciences (IGS). She is an internationally-recognized researcher known for her work in integrating spatial multi-omics technologies with mathematical models to develop a new predictive medicine paradigm in cancer. Spatial technologies allow researchers to learn about any cell type inside of natural tissue, including gene activity and cell interactions.
Thursday, August 22, 2024
Gallery: UM Joins Community Block Party to Address Healthcare Needs in West Baltimore
On August 10, Dean Mark T. Gladwin, MD, and Esa Davis, MD, MPH, Associate Vice President for Community Health at the University of Maryland, Baltimore (UMB) and Senior Associate Dean for Population and Community Medicine, took part in the annual Summers in the 7th Block Party at The Village at Mondawmin.
Wednesday, August 14, 2024
Patients with Unexplainable Chronic Itch Have Unique Blood Biomarkers that Could Eventually Lead to New Targeted Treatments
Millions of patients worldwide suffer from a chronic itching condition with no identifiable cause – a condition known as chronic pruritus of unknown origin (CPUO) – that has no targeted therapies approved to treat it. Many of these patients suffer for years with little relief, but a new University of Maryland School of Medicine study may provide hope for future treatments. Patients were found to have lower than normal levels of metabolite biomarkers in the blood plasma that could point to a cause of their excruciating symptoms.
Monday, August 12, 2024
Longtime Chair of Epidemiology & Public Health, Dr. Jay Magaziner, to Step Down as Chair
UMSOM Dean, Mark T. Gladwin, MD, announced today that Jay Magaziner, PhD, MSHyg, has decided to step down at the end of the academic year from his role as Chair of the Department of Epidemiology & Public Health after 17 years of dynamic leadership and academic achievement.
Wednesday, August 07, 2024
Nationally Recognized Behavioral Scientist Dr. Kelly Dunn Named Director of the Kahlert Institute for Addiction Medicine at the University of Maryland School of Medicine
UMSOM Dean Mark T. Gladwin, MD, announced today the appointment of Kelly Dunn, PhD, MBA, one of the nation’s leading researchers on opioid use disorder, as the inaugural Director of the School’s Kahlert Institute for Addiction Medicine. Dr. Dunn is currently a Professor of Psychiatry and Behavioral Sciences at Johns Hopkins School of Medicine with a joint appointment in Health Policy and Management at the Johns Hopkins University School of Public Health. Dr. Dunn has been the Principal Investigator on projects totaling more than $21 million in awards from the National Institutes of Health. She has authored more than 130 peer-reviewed publications in the area of substance use and opioid use disorder.